| Likelihood of accepting enfuvirtide | ||
---|---|---|---|
 | Likely a | Moderately likely b | Unlikely c |
 | (n = 180) | (n = 214) | (n = 122) |
 | Mean (SD) | Mean (SD) | Mean (SD) |
Perception that enfuvirtide is more effective and preferable to oral therapy (F [2502] = 102.5, p < 0.001) | 4.39 (1.26) | 3.34 (1.08) | 2.53 (0.91) |
Perceived barriers to adherence (F [2503] = 77.26, p < 0.001) | 2.45 (1.20) | 3.52 (1.27) | 4.27 (1.37) |
Concerns about self injecting (F [2513] = 36.0, p < 0.001) | 2.65 (1.14)* | 3.29 (1.08)* | 3.74 (1.18) |
Resistance to doctor recommending self-injectable therapies (F [2513] = 72.2, p < 0.001) | 1.90 (1.12) | 2.95 (1.35) | 3.76 (1.61) |
Perception that doctors have positive views about enfuvirtide (F [2233] = 8.66, p < 0.001) | 1.57 (0.50) | 1.35 (0.48) | 1.23 (0.42) |